A groundbreaking approach slows tumor growth while boosting the immune system’s defense against cancer cells. Prostate cancer ranks as the second most common cancer among men globally. Despite recent ...

Radiation therapy is a standard treatment option, especially for those with localized prostate cancer. However, the side ...

Although September is known as Prostate Cancer Awareness Month, I have chosen to tell my prostate journey for Movember, Men’s ...

Prostate cancer is the most common cancer in men in the United States aside from skin cancer. Dr. Jose Avitia, a medical ...

According to the 2019 National Cancer Registry the lifetime risk for prostate cancer in South Africa is 1 in every 15 man. Prostate cancer is the most common cancer in men globally and is showing a ...

Philadelphia, November 12, 2024 – The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from ...

versus hormone therapy in patients with metastatic castration-resistant prostate cancer. The ECLIPSE trial demonstrated a statistically significant and clinically meaningful improvement in the median ...

A research team led by UCLA Health Jonsson Comprehensive Cancer Center investigators has shown that that combining pembrolizumab, an immunotherapy drug, with standard chemotherapy can improve ...

Metastatic castration-resistant prostate cancer (mCRPC) is a severe form of late-stage disease where the tumor can no longer ...

“Prostate cancer patients with life expectancies of less than five or 10 years were being subjected to treatments that can ...

The treatment landscape for patients with prostate cancer, especially individuals with advanced disease, has dramatically changed in recent years. However, aside from drug or hormonal therapies, other ...

Routt County resident James Onufrak knew his dad was diagnosed with prostate cancer at age 61, so he worked with his own ...